Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 22,897	$ 33,776
General and administrative	6,815	7,283
Total operating expenses	29,712	41,059
Loss from operations	(29,712)	(41,059)
Interest and other income, net	450	1,998
Net and comprehensive loss	$ (29,262)	$ (39,061)
Net loss per common share, basic	$ (0.8)	$ (1.09)
Net loss per common share, diluted	$ (0.8)	$ (1.09)
Weighted-average number of common shares used to compute basic net loss per common share	36,627,148	35,890,370
Weighted-average number of common shares used to compute diluted net loss per common share	36,627,148	35,890,370